Respiratory inhaler devices are essential tools for delivering medication directly into the lungs for the treatment and management of respiratory conditions such as asthma, chronic obstructive ...

Pune, Oct. 30, 2020 (GLOBE NEWSWIRE) -- The global smart inhalers market size is set to gain impetus from the rising utilization of digital technology in the field of healthcare devices. It is aiding ...

Jerusalem-based Teva Pharmaceuticals’ sensor-packed, app-connected digital inhaler has recently received marketing approval from the US FDA, according to a release from the company. The device will ...

Asthma and COPD Drugs Market is expected to reach US$ 82.2 Billion by 2036, driven by Advancements in Drug Discovery and ...

NEW YORK, July 31, 2024 /PRNewswire/ -- The global smart inhaler technology market size is estimated to grow by USD 46.37 million from 2023-2027, according to Technavio. The market is estimated to ...

Biopharmaceutical company Opko Health has acquired Israeli smart inhaler company Inspiro Medical for a sum in "the low eight figures", according to Opko's Director of Strategic Investment Les ...

Switching from a metered-dose to a dry-powder inhaler after a formulary change increased emergency department visits and hospitalizations in people with COPD or asthma. The absolute changes in risk ...